Locations:
Search
Even high-risk patients see long-term benefit
Study examines the relationship between outcomes and delay
New study examines rates of downgrading in patients with aggressive prostate cancer
A multidisciplinary approach from prenatal to adult
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A closer look at the innovative procedure
Durvalumab monotherapy appears safe and well-tolerated
Life plan for a lifeline replaces the “fistula first” initiative
Study finds that childless men who received a vasectomy are unlikely to change their minds in the future
A nephrologist at Cleveland Clinic shares possible theories
Advertisement
Advertisement
